LIF and hepatocellular carcinoma: For instance, in HCC, LIF/LIFR anti-metastatic properties are due to the negative regulation of another LIF-regulated signalling pathway which is the PI3K/AKT pathway [24], again showing the complexity of LIF/LIFR signal transduction.